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Blood culture records from 1994 to 1995 from five U.S. medical centers all using the Difco ESP continuous
monitoring blood culture system were reviewed retrospectively. Among a total of 7,362 isolates of bacteria and
yeasts, only 0.1% of possibly significant isolates would have been missed had blood cultures been routinely
incubated for 4 days instead of the 5 days recommended by the manufacturer. Conversely, numerous contam-
inants, detected only on day 5, would have been eliminated by a 4-day incubation period.
Three different continuous monitoring blood culture systems
have achieved widespread application in the United States: the
BAC TEC 9240 system (Becton Dickinson Microbiology Sys-
tems, Cockeysville, Md.), the ESP system (Difco Laboratories,
Detroit, Mich.), and the BacT/Alert system (Organon Teknika,
Durham, N.C.) (3–9, 11). Each manufacturer recommends a
5-day incubation period for blood culture bottles before they
are discarded as negative, and there are studies to support this
length of incubation for the BacT/Alert instrument (1, 10). To
our knowledge, however, there are no published data specifi-
cally addressing the optimum duration of incubation of blood
culture bottles with the Difco ESP system. The goal of this
study was to systematically examine this issue.
Archived blood culture records covering 7- to 12-month
periods between 1994 and 1995 from five medical centers were
examined (Table 1). Three hospitals were in academic medical
centers. All five hospitals provided tertiary care in a referral
setting but also offered many ambulatory-care services. Pri-
mary and tertiary care in pediatrics were provided by all five
participating hospitals, as were transplantation and trauma
services and care to large human immunodeficiency virus-in-
fected patient populations. Each of the centers used the Difco
ESP system as the primary method of blood culture analysis.
When sufficient blood was available for culture, up to 20 ml
was routinely collected and distributed equally into one aero-
bic (40A or 80A medium) and one anaerobic (40N or 80N
medium) blood culture bottle. In circumstances where #10 ml
of blood could be obtained, the aerobic bottle was usually the
only bottle inoculated. All blood cultures were processed pre-
cisely according to the manufacturer’s instructions and incu-
bated for 5 days before being reported as negative.
For the purpose of data analysis, non-Staphylococcus aureus
staphylococci, Corynebacterium spp. other than Corynebacte-
rium jeikeium,Micrococcus spp., Bacillus spp., and Propionibac-
terium spp. were considered probable contaminants under the
following circumstances: (i) when the isolate was recovered
from only one of two blood culture bottles of a set when only
a single set was drawn or (ii) when the isolate was recovered
from both bottles of a blood culture set when additional blood
culture or intravascular catheter tip cultures performed on the
same patient within a 24 h period of the index-positive culture
were negative. All other blood culture isolates were considered
likely to have clinical significance.
A summary of the length of time required to detect individ-
ual blood culture isolates at all study sites is shown in Table 2.
The observations of the individual laboratories were compara-
ble to the combined results. A total of 7,362 blood culture
isolates were recovered. As can be seen in Table 2, 63.2% of all
isolates were detected during the first 24 h of incubation, while
an additional 25.4% of blood culture isolates were recognized
on day 2 and 6.5% were recognized on day 3. Only 2.7 and
2.2% of isolates were recovered on days 4 and 5, respectively.
Among individual organism groups, 96.1% of all enterococci,
96% of all members of the family Enterobacteriaceae, 96.4% of
all Pseudomonas aeruginosa strains, 89.4% of all S. aureus
strains, and 100% of all pneumococci and group A and B
beta-hemolytic streptococci were detected within 48 h of incu-
bation. Ninety-seven percent of the latter three categories of
organisms were detected within the first 24 h of incubation.
Among the 164 isolates recovered on day 5, all but 8 isolates
were either classified as probable contaminants (n 5 120;
* Corresponding author. Mailing address: Clinical Microbiology
Laboratories, University of Massachusetts Medical Center, 55 Lake
Ave. North, Worcester, MA 01655. Phone: (508) 856-6417. Fax: (508)
856-1537.
TABLE 1. Participating centers and study characteristics
Medical center Study perioda
No. of blood
cultures
performed
Baptist Medical Center,
Jacksonville, Fla.
26 Jan. 1995 to
31 Aug. 1995
ca. 8,000
University of Florida
Health Science Center,
Jacksonville, Fla.
24 Jan. 1995 to
12 Aug. 1995
5,760
University of New Mexico
Medical Center,
Albuquerque, N. Mex.
1 Jan. 1995 to
31 Oct. 1995
23,167
Henry Ford Hospital,
Detroit, Mich.
1 Nov. 1994 to
1 Oct. 1995
ca. 40,000
University of Massachusetts
Medical Center,
Worcester, Mass.
1 July 1994 to
30 June 1995
14,337
a Jan., January; Aug., August; Oct., October; Nov., November.
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73.2%) or had been recovered within 4 days of incubation from
another blood culture taken from the same patient (n 5 36;
22.0%). The eight exceptions included four isolates of Kleb-
siella pneumoniae, two isolates of S. aureus, and one isolate
each of Serratia marcescens and Enterobacter aerogenes. There-
fore, only 8 presumed clinically significant blood culture iso-
lates from a total of 7,362 isolates (0.1%) were detected ex-
clusively on the fifth day of incubation.
The present study was marked by two shortcomings. First,
the definitions used to classify blood culture isolates as con-
taminants did not take into account clinical information and, as
a result, were not strictly inclusive. The criteria employed were
chosen so as to permit consistent classification of contaminants
among all five participating laboratories. Undoubtedly, certain
contaminated blood cultures were misclassified as possibly sig-
nificant. Such errors, however, would not have altered our
TABLE 2. Recovery of blood culture isolates by day of incubation
Organism
No. (%) of isolates recovered on day:
1 2 3 4 5
Staphylococcus aureus 666 (63.4) 273 (26.0) 63 (6.0) 31 (3.0) 16 (1.5)
Non-Staphylococcus aureus staphylococci 1,467 (51.3) 978 (34.2) 258 (9.0) 94 (3.3) 61 (2.1)
Micrococcus spp. 6 (20.7) 19 (65.5) 4 (13.8) 0 0
Streptococcus pneumoniae 298 (97.1) 9 (2.9) 0 0 0
Group A streptococci 53 (94.6) 3 (5.4) 0 0 0
Group B streptococci 75 (98.7) 1 (1.3) 0 0 0
Group C, G, or F streptococci 21 (87.5) 3 (12.5) 0 0 0
Enterococcus spp. 331 (80.1) 66 (16.0) 10 (2.4) 5 (1.2) 1 (0.2)
Viridans group streptococci 312 (74.8) 79 (18.9) 17 (4.1) 8 (1.9) 1 (0.2)
Streptococcus bovis 15 (100) 0 0 0 0
Nutritionally variant streptococci 1 (33.3) 1 (33.3) 1 (33.3) 0 0
Moraxella catarrhalis 2 (100) 0 0 0 0
Moraxella spp. 1 (50) 1 (50) 0 0 0
Neisseria meningitidis 5 (71.4) 2 (28.6) 0 0 0
Neisseria spp. 4 (57.1) 3 (42.9) 0 0 0
Listeria monocytogenes 8 (100) 0 0 0 0
Corynebacterium spp. 30 (15.5) 89 (46.1) 38 (20.0) 16 (8.3) 20 (10.4)
Lactobacillus spp. 2 (14.3) 5 (35.7) 3 (21.4) 3 (21.4) 1 (7.1)
Bacillus spp. 94 (70.7) 24 (18.0) 12 (9.0) 1 (0.8) 2 (1.5)
Escherichia coli 504 (87.0) 66 (11.4) 3 (0.5) 3 (0.5) 3 (0.5)
Klebsiella pneumoniae 170 (85.4) 17 (8.5) 7 (3.5) 1 (0.5) 4 (2.0)
Klebsiella spp. 23 (79.3) 4 (13.8) 0 1 (3.4) 1 (3.4)
Enterobacter cloacae 116 (84.7) 13 (9.5) 2 (1.5) 4 (2.9) 2 (1.5)
Enterobacter spp. 32 (76.2) 5 (11.9) 3 (7.1) 1 (2.4) 1 (2.4)
Citrobacter freundii 14 (93.3) 1 (6.7) 0 0 0
Citrobacter diversus 7 (100) 0 0 0 0
Serratia marcescens 38 (67.9) 14 (25.0) 0 2 (3.6) 2 (3.6)
Proteus mirabilis 46 (90.2) 3 (5.9) 1 (2.0) 1 (2.0) 0
Proteus vulgaris 0 0 0 0 0
Providencia spp. 3 (100) 0 0 0 0
Morganella morganii 8 (66.7) 0 3 (25.0) 1 (8.3) 0
Hafnia alvei 1 (25.0) 3 (75.0) 0 0 0
Salmonella spp. 9 (100) 0 0 0 0
Other enteric gram-negative bacilli 4 (80.0) 1 (20.0) 0 0 0
Pseudomonas aeruginosa 150 (77.3) 37 (19.1) 2 (1.0) 5 (2.6) 0
Acinetobacter spp. 61 (89.7) 4 (5.9) 0 3 (4.4) 0
Stenotrophomonas maltophilia 28 (82.4) 4 (11.8) 2 (5.9) 0 0
Alcaligenes spp. 9 (64.3) 3 (21.4) 2 (14.3) 0 0
Campylobacter spp. 0 4 (100) 0 0 0
Haemophilus influenzae 6 (75.0) 2 (25.0) 0 0 0
Miscellaneous gram-negative bacilli 32 (72.7) 7 (15.9) 4 (9.1) 1 (2.3) 0
Peptostreptococcus spp. 5 (25.0) 8 (40.0) 4 (20.0) 0 3 (15.0)
Clostridium perfringens 20 (90.9) 1 (4.5) 0 1 (4.5) 0
Clostridium spp. 16 (66.7) 5 (20.8) 1 (4.2) 1 (4.2) 1 (4.2)
Propionibacterium spp. 1 (2.1) 4 (8.3) 2 (4.2) 0 41 (85.4)
Actinomyces spp. 0 4 (57.1) 3 (42.9) 0 0
Other anaerobic NSF gram-positive bacillia 0 1 (25.0) 0 3 (75.0) 0
Bacteroides fragilis group 17 (28.8) 30 (50.8) 9 (15.3) 3 (5.1) 0
Other Bacteroides spp. 3 (37.5) 3 (37.5) 2 (25.0) 0 0
Prevotella spp. 4 (44.4) 2 (22.2) 3 (33.3) 0 0
Fusobacterium spp. 6 (31.6) 4 (21.1) 4 (21.1) 4 (21.1) 1 (5.3)
Candida albicans 15 (15.6) 53 (55.2) 19 (19.8) 9 (9.4) 0
Non-Candida albicans candidas 12 (18.8) 38 (59.4) 6 (9.4) 0 8 (12.5)
Torulopsis glabrata 6 (27.3) 13 (59.1) 2 (9.1) 1 (4.5) 0
Total 4,757 (63.2) 1,910 (25.4) 490 (6.5) 204 (2.7) 169 (2.2)
a NSF, non-spore-forming.
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findings since only 8 possibly significant isolates were recov-
ered exclusively on day 5. Second, the incubation period in all
laboratories was terminated after day 5 with no blind subcul-
tures performed on instrument-negative cultures. The question
of what would have been detected either by prolonging the
incubation period beyond day 5 or by performing blind sub-
cultures can be asked, but obviously it cannot be answered with
certainty. In general, blind subcultures of negative bottles from
instrument-based blood culture systems have been shown to be
unnecessary (1, 2). Furthermore, examination of rates of de-
tection by day of incubation in the current study suggested that
there would have been little if any additional yield beyond the
5-day incubation period. Recovery rates fell off conspicuously
after day 2 of incubation, 72 h prior to the end of the 5-day
incubation period.
Based on the results of this survey, we conclude that short-
ening the length of incubation of aerobic and anaerobic blood
culture bottles inoculated with ca. 10 ml of blood and pro-
cessed with the Difco ESP blood culture system from 5 to 4
days would not significantly diminish the utility of this system
as a means of detecting significant bacteremia and candidemia.
A favorable ramification of such a change would be the reduc-
tion of the number of contaminants recovered. The only or-
ganism recovered frequently as a significant blood culture iso-
late for which a 4-day incubation cycle with the ESP blood
culture system might be problematic was K. pneumoniae. In
circumstances where blood cultures are performed on patients
likely to have K. pneumoniae bacteremia, e.g., intensive care
unit outbreak situations and cases associated with isolation of
this organism from other body sites, it may be prudent to
incubate ESP blood cultures for at least 5 days. It should be
emphasized that these observations are applicable only to the
Difco ESP blood culture system. Surveys like this one must be
conducted with other continuous-monitoring blood culture
methods before similar recommendations can be made for
these systems.
We are indebted to the laboratory staffs of their respective labora-
tories for excellent technical assistance. We also thank Deborah
McQuaid for secretarial support.
This survey was supported by a grant from Difco Laboratories.
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